Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Cirrhosis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 45 articles:
HTML format
Text format



Single Articles


    September 2017

  1. Erratum: The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2017;66:1730.
    PubMed     Text format    


    July 2017
  2. ALBANO E, Stickel F
    Targeting toll-like receptor 7/8 improves host anti-infective response in alcoholic cirrhosis.
    Gut. 2017 Jul 7. pii: gutjnl-2017-314437. doi: 10.1136/gutjnl-2017-314437.
    PubMed     Text format    


    June 2017
  3. ROLAS L, Boussif A, Weiss E, Letteron P, et al
    NADPH oxidase depletion in neutrophils from patients with cirrhosis and restoration via toll-like receptor 7/8 activation.
    Gut. 2017 Jun 10. pii: gutjnl-2016-313443. doi: 10.1136/gutjnl-2016-313443.
    PubMed     Text format     Abstract available


  4. BAJAJ JS, Liu EJ, Kheradman R, Fagan A, et al
    Fungal dysbiosis in cirrhosis.
    Gut. 2017 Jun 3. pii: gutjnl-2016-313170. doi: 10.1136/gutjnl-2016-313170.
    PubMed     Text format     Abstract available


  5. ARRIAZU E, Ge X, Leung TM, Magdaleno F, et al
    Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
    Gut. 2017;66:1123-1137.
    PubMed     Text format     Abstract available


    May 2017
  6. BREITKOPF-HEINLEIN K, Meyer C, Konig C, Gaitantzi H, et al
    BMP-9 interferes with liver regeneration and promotes liver fibrosis.
    Gut. 2017;66:939-954.
    PubMed     Text format     Abstract available


    January 2017
  7. MENARD A, Aherfi S, Mokhtari S, Dhiver C, et al
    Toward chronic hepatitis C eradication in HIV-positive patients, including those cirrhotic and infected with genotype 3 viruses.
    Gut. 2017 Jan 10. pii: gutjnl-2016-313431. doi: 10.1136/gutjnl-2016-313431.
    PubMed     Text format    


    September 2016
  8. KUTTKAT N, Mohs A, Ohl K, Hooiveld G, et al
    Hepatic overexpression of cAMP-responsive element modulator alpha induces a regulatory T-cell response in a murine model of chronic liver disease.
    Gut. 2016 Sep 29. pii: gutjnl-2015-311119. doi: 10.1136/gutjnl-2015-311119.
    PubMed     Text format     Abstract available


    August 2016

  9. Erratum: Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis.
    Gut. 2016;65:1394.
    PubMed     Text format    


    July 2016
  10. HACKSTEIN CP, Assmus LM, Welz M, Klein S, et al
    Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis.
    Gut. 2016 Jul 18. pii: gutjnl-2015-311224. doi: 10.1136/gutjnl-2015-311224.
    PubMed     Text format     Abstract available


    June 2016
  11. BHARDWAJ A, Kedarisetty CK, Vashishtha C, Bhadoria AS, et al
    Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis: a randomised placebo-controlled trial.
    Gut. 2016 Jun 13. pii: gutjnl-2016-311735. doi: 10.1136/gutjnl-2016-311735.
    PubMed     Text format     Abstract available


    May 2016
  12. NJEI B, McCarty TR, Garcia-Tsao G
    Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters.
    Gut. 2016 May 20. pii: gutjnl-2016-312129. doi: 10.1136/gutjnl-2016-312129.
    PubMed     Text format    


    April 2016
  13. O'BRIEN A, China L
    Is human albumin solution really the best resuscitation fluid for patients with advanced cirrhosis?
    Gut. 2016 Apr 27. pii: gutjnl-2016-311999. doi: 10.1136/gutjnl-2016-311999.
    PubMed     Text format    


  14. BOYD A, Bottero J, Lacombe K
    The gamma-glutamyl transpeptidase-to-platelet ratio as a predictor of liver fibrosis in patients co-infected with HBV and HIV.
    Gut. 2016;65:718-20.
    PubMed     Text format    


    March 2016
  15. BRITO-AZEVEDO A, Perez RM, Coelho HS, Fernandes ES, et al
    Propranolol improves endothelial dysfunction in advanced cirrhosis: the 'endothelial exhaustion' hypothesis.
    Gut. 2016 Mar 16. pii: gutjnl-2016-311696. doi: 10.1136/gutjnl-2016-311696.
    PubMed     Text format    


  16. KALAMBOKIS GN, Baltayiannis G, Christou L, Christodoulou D, et al
    Red signs and not severity of cirrhosis should determine non-selective beta-blocker treatment in Child-Pugh C cirrhosis with small varices: increased risk of hepatorenal syndrome and death beyond 6 months of propranolol use.
    Gut. 2016 Mar 2. pii: gutjnl-2016-311527. doi: 10.1136/gutjnl-2016-311527.
    PubMed     Text format    


  17. ZHAO XL, Yang JR, Lin SZ, Ma H, et al
    Serum viral duplex-linear DNA proportion increases with the progression of liver disease in patients infected with HBV.
    Gut. 2016;65:502-11.
    PubMed     Text format     Abstract available


  18. ICHOU L, Carbonell N, Rautou PE, Laurans L, et al
    Ascitic fluid TREM-1 for the diagnosis of spontaneous bacterial peritonitis.
    Gut. 2016;65:536-8.
    PubMed     Text format    


    January 2016
  19. STOCKDALE AJ, Phillips RO, Geretti AM
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) shows poor correlation with transient elastography measurements of liver fibrosis in HIV-positive patients with chronic hepatitis B in West Africa. Response to: 'The gamma-glutamyl transpeptida
    Gut. 2016 Jan 4. pii: gutjnl-2015-311133. doi: 10.1136/gutjnl-2015-311133.
    PubMed     Text format    


    December 2015
  20. HU HH, Liu J, Lin YL, Luo WS, et al
    The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B.
    Gut. 2015 Dec 7. pii: gutjnl-2015-310686. doi: 10.1136/gutjnl-2015-310686.
    PubMed     Text format     Abstract available


    October 2015
  21. NAHON P, Lescat M, Layese R, Bourcier V, et al
    Bacterial infection in compensated viral cirrhosis impairs 5-year survival (ANRS CO12 CirVir prospective cohort).
    Gut. 2015 Oct 28. pii: gutjnl-2015-310275. doi: 10.1136/gutjnl-2015-310275.
    PubMed     Text format     Abstract available


    September 2015
  22. KLEIN S, Rick J, Lehmann J, Schierwagen R, et al
    Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis.
    Gut. 2015 Sep 17. pii: gutjnl-2015-309600. doi: 10.1136/gutjnl-2015-309600.
    PubMed     Text format     Abstract available


  23. BEUERS U, Gershwin ME, Gish RG, Invernizzi P, et al
    Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'.
    Gut. 2015 Sep 14. pii: gutjnl-2015-310593. doi: 10.1136/gutjnl-2015-310593.
    PubMed     Text format    


    August 2015
  24. ZEISEL MB, Lucifora J, Mason WS, Sureau C, et al
    Towards an HBV cure: state-of-the-art and unresolved questions--report of the ANRS workshop on HBV cure.
    Gut. 2015;64:1314-26.
    PubMed     Text format     Abstract available


    July 2015
  25. COOMBES JD, Swiderska-Syn M, Dolle L, Reid D, et al
    Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice.
    Gut. 2015;64:1120-31.
    PubMed     Text format     Abstract available


    June 2015
  26. LEMOINE M, Shimakawa Y, Nayagam S, Khalil M, et al
    The gamma-glutamyl transpeptidase to platelet ratio (GPR) predicts significant liver fibrosis and cirrhosis in patients with chronic HBV infection in West Africa.
    Gut. 2015 Jun 24. pii: gutjnl-2015-309260. doi: 10.1136/gutjnl-2015-309260.
    PubMed     Text format     Abstract available


  27. ZHANG DY, Goossens N, Guo J, Tsai MC, et al
    A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.
    Gut. 2015 Jun 4. pii: gutjnl-2015-309655. doi: 10.1136/gutjnl-2015-309655.
    PubMed     Text format     Abstract available


  28. BEDRELI S, Sowa JP, Gerken G, Saner FH, et al
    Management of acute-on-chronic liver failure: rotational thromboelastometry may reduce substitution of coagulation factors in liver cirrhosis.
    Gut. 2015 Jun 3. pii: gutjnl-2015-309922. doi: 10.1136/gutjnl-2015-309922.
    PubMed     Text format    


    May 2015
  29. TAKUMA Y, Nouso K, Morimoto Y, Tomokuni J, et al
    Prediction of oesophageal variceal bleeding by measuring spleen stiffness in patients with liver cirrhosis.
    Gut. 2015 May 25. pii: gutjnl-2015-309741. doi: 10.1136/gutjnl-2015-309741.
    PubMed     Text format    


  30. LEE YA, Wallace MC, Friedman SL
    Pathobiology of liver fibrosis: a translational success story.
    Gut. 2015;64:830-41.
    PubMed     Text format     Abstract available


    April 2015
  31. MOREAU R
    Stimulating hepatocyte renewal: a new paradigm for the treatment of severe alcoholic hepatitis unresponsive to corticosteroids?
    Gut. 2015 Apr 3. pii: gutjnl-2015-309545. doi: 10.1136/gutjnl-2015-309545.
    PubMed     Text format    


  32. PLOMPEN EP, Hansen BE, Schouten JN, Darwish Murad S, et al
    Interferon gamma receptor 2 gene variants are associated with liver fibrosis in the general population: the Rotterdam Study.
    Gut. 2015;64:692-4.
    PubMed     Text format    


    March 2015
  33. GIANNINI EG, Savarino V
    An independent validation of the mortality score for the short-term prognostic prediction in patients with chronic HCV infection and advanced liver disease.
    Gut. 2015 Mar 24. pii: gutjnl-2015-309440. doi: 10.1136/gutjnl-2015-309440.
    PubMed     Text format    


  34. DUBUQUOY L, Louvet A, Lassailly G, Truant S, et al
    Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis.
    Gut. 2015 Mar 2. pii: gutjnl-2014-308410. doi: 10.1136/gutjnl-2014-308410.
    PubMed     Text format     Abstract available


    February 2015
  35. MORALES-IBANEZ O, Affo S, Rodrigo-Torres D, Blaya D, et al
    Kinase analysis in alcoholic hepatitis identifies p90RSK as a potential mediator of liver fibrogenesis.
    Gut. 2015 Feb 4. pii: gutjnl-2014-307979. doi: 10.1136/gutjnl-2014-307979.
    PubMed     Text format     Abstract available


    January 2015
  36. TREBICKA J, Schierwagen R
    Statins, Rho GTPases and KLF2: new mechanistic insight into liver fibrosis and portal hypertension.
    Gut. 2015 Jan 16. pii: gutjnl-2014-308800. doi: 10.1136/gutjnl-2014-308800.
    PubMed     Text format    


    December 2014
  37. JOOSSE ME, Schipper ME, Libbrecht L, Buuren HR, et al
    Recurrent cholangitis in a 65-year-old man.
    Gut. 2014 Dec 22. pii: gutjnl-2014-308726. doi: 10.1136/gutjnl-2014-308726.
    PubMed     Text format    


    September 2014
  38. RUEGER S, Bochud PY, Dufour JF, Mullhaupt B, et al
    Impact of common risk factors of fibrosis progression in chronic hepatitis C.
    Gut. 2014 Sep 11. pii: gutjnl-2014-306997. doi: 10.1136/gutjnl-2014-306997.
    PubMed     Text format     Abstract available


  39. BARTOSCH B
    Piecing together the key players of fibrosis in chronic hepatitis C: what roles do non-hepatic liver resident cell types play?
    Gut. 2014 Sep 8. pii: gutjnl-2014-307957. doi: 10.1136/gutjnl-2014-307957.
    PubMed     Text format    


    August 2014
  40. BEILFUSS A, Sowa JP, Sydor S, Beste M, et al
    Vitamin D counteracts fibrogenic TGF-beta signalling in human hepatic stellate cells both receptor-dependently and independently.
    Gut. 2014 Aug 18. pii: gutjnl-2014-307024. doi: 10.1136/gutjnl-2014-307024.
    PubMed     Text format     Abstract available


    July 2014
  41. FLORIMOND A, Chouteau P, Bruscella P, Le Seyec J, et al
    Human hepatic stellate cells are not permissive for hepatitis C virus entry and replication.
    Gut. 2014 Jul 25. pii: gutjnl-2013-305634. doi: 10.1136/gutjnl-2013-305634.
    PubMed     Text format     Abstract available


  42. MACHADO MV, Michelotti GA, Pereira TD, Boursier J, et al
    Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.
    Gut. 2014 Jul 22. pii: gutjnl-2014-307362. doi: 10.1136/gutjnl-2014-307362.
    PubMed     Text format     Abstract available


  43. ARNDT S, Wacker E, Dorn C, Koch A, et al
    Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
    Gut. 2014 Jul 10. pii: gutjnl-2014-306968. doi: 10.1136/gutjnl-2014-306968.
    PubMed     Text format     Abstract available


  44. LIM TH, Gane E, Moyes C, Borman B, et al
    Serological and clinical outcomes of horizontally transmitted chronic hepatitis B infection in New Zealand Maori: results from a 28-year follow-up study.
    Gut. 2014 Jul 8. pii: gutjnl-2013-306247. doi: 10.1136/gutjnl-2013-306247.
    PubMed     Text format     Abstract available


    May 2014
  45. MEJIAS M, Coch L, Berzigotti A, Garcia-Pras E, et al
    Antiangiogenic and antifibrogenic activity of pigment epithelium-derived factor (PEDF) in bile duct-ligated portal hypertensive rats.
    Gut. 2014 May 21. pii: gutjnl-2014-307138. doi: 10.1136/gutjnl-2014-307138.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Cirrhosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: